These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Consistency in efficacy and safety of ezetimibe coadministered with statins for treatment of hypercholesterolemia in women and men. Bennett S; Sager P; Lipka L; Melani L; Suresh R; Veltri E; J Womens Health (Larchmt); 2004 Dec; 13(10):1101-7. PubMed ID: 15650343 [TBL] [Abstract][Full Text] [Related]
3. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety. Hou R; Goldberg AC Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513 [TBL] [Abstract][Full Text] [Related]
4. Effect of ezetimibe in patients who cannot tolerate statins or cannot get to the low density lipoprotein cholesterol target despite taking a statin. Gazi IF; Daskalopoulou SS; Nair DR; Mikhailidis DP Curr Med Res Opin; 2007 Sep; 23(9):2183-92. PubMed ID: 17692154 [TBL] [Abstract][Full Text] [Related]
5. Effect of ezetimibe on low-density lipoprotein subtype distribution: results of a placebo-controlled, double-blind trial in patients treated by regular low-density lipoprotein apheresis and statins. Geiss HC; Otto C; Parhofer KG Metabolism; 2006 May; 55(5):599-604. PubMed ID: 16631435 [TBL] [Abstract][Full Text] [Related]
6. Effect of statins on noncholesterol sterol levels: implications for use of plant stanols and sterols. Miettinen TA; Gylling H Am J Cardiol; 2005 Jul; 96(1A):40D-46D. PubMed ID: 15992515 [TBL] [Abstract][Full Text] [Related]
8. [Drug therapy of hypercholesterolemia. Treatment of hypercholesterolemia in adults--a Norwegian therapeutic program 1988]. Ose L; Blomhoff JP; Torsvik H Tidsskr Nor Laegeforen; 1989 Mar; 109(7-8):850-2. PubMed ID: 2705170 [TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamic interaction between ezetimibe and rosuvastatin. Kosoglou T; Statkevich P; Yang B; Suresh R; Zhu Y; Boutros T; Maxwell SE; Tiessen R; Cutler DL Curr Med Res Opin; 2004 Aug; 20(8):1185-95. PubMed ID: 15324521 [TBL] [Abstract][Full Text] [Related]
10. The impact of ezetimibe and high-dose of statin treatment on LDL levels in patients with heterozygous familial hypercholesterolemia. Pitsavos C; Skoumas I; Tousoulis D; Metalinos G; Masoura C; Chrysohoou C; Papadimitriou L; Giotsas N; Toutouza M; Antoniades C; Stefanadis C Int J Cardiol; 2009 May; 134(2):280-1. PubMed ID: 18353459 [TBL] [Abstract][Full Text] [Related]
11. Safety and effectiveness of ezetimibe in liver transplant recipients with hypercholesterolemia. Almutairi F; Peterson TC; Molinari M; Walsh MJ; Alwayn I; Peltekian KM Liver Transpl; 2009 May; 15(5):504-8. PubMed ID: 19399742 [TBL] [Abstract][Full Text] [Related]
12. Reaching goal in hypercholesterolaemia: dual inhibition of cholesterol synthesis and absorption with simvastatin plus ezetimibe. Daskalopoulou SS; Mikhailidis DP Curr Med Res Opin; 2006 Mar; 22(3):511-28. PubMed ID: 16574035 [TBL] [Abstract][Full Text] [Related]
13. Ezetimibe: new preparation. A cholesterol-lowering drug with no clinical advantage. Prescrire Int; 2004 Oct; 13(73):176-9. PubMed ID: 15499698 [TBL] [Abstract][Full Text] [Related]
15. Plant sterols and their role in combined use with statins for lipid lowering. Normén L; Holmes D; Frohlich J Curr Opin Investig Drugs; 2005 Mar; 6(3):307-16. PubMed ID: 15816508 [TBL] [Abstract][Full Text] [Related]
16. Effects of fluvastatin extended-release (80 mg) alone and in combination with ezetimibe (10 mg) on low-density lipoprotein cholesterol and inflammatory parameters in patients with primary hypercholesterolemia: a 12-week, multicenter, randomized, open-label, parallel-group study. Alvarez-Sala LA; Cachofeiro V; Masana L; Suarez C; Pinilla B; Plana N; Trias F; Moreno MA; Gambus G; Lahera V; Pintó X Clin Ther; 2008 Jan; 30(1):84-97. PubMed ID: 18343245 [TBL] [Abstract][Full Text] [Related]
17. Pooled analyses of effects on C-reactive protein and low density lipoprotein cholesterol in placebo-controlled trials of ezetimibe monotherapy or ezetimibe added to baseline statin therapy. Pearson TA; Ballantyne CM; Veltri E; Shah A; Bird S; Lin J; Rosenberg E; Tershakovec AM Am J Cardiol; 2009 Feb; 103(3):369-74. PubMed ID: 19166691 [TBL] [Abstract][Full Text] [Related]
18. Clinical use of ezetimibe. Cheng AY; Leiter LA Can J Clin Pharmacol; 2003; 10 Suppl A():21A-5A. PubMed ID: 14571302 [TBL] [Abstract][Full Text] [Related]
19. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin. Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E; Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231 [TBL] [Abstract][Full Text] [Related]
20. The benefit of fibrates in the treatment of 'bad HDL-C responders to statins'. Devroey D; Velkeniers B; Duquet W; Betz W Int J Cardiol; 2005 May; 101(2):231-5. PubMed ID: 15882669 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]